- Home
- BBNX vs SABR Comparison
BBNX vs SABR Comparison
Compare BBNX & SABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBNX
- SABR
- Stock Information
- Founded
- BBNX 2015
- SABR 2006
- Country
- BBNX United States
- SABR United States
- Employees
- BBNX N/A
- SABR N/A
- Industry
- BBNX Medical/Dental Instruments
- SABR Computer Software: Programming Data Processing
- Sector
- BBNX Health Care
- SABR Technology
- Exchange
- BBNX Nasdaq
- SABR Nasdaq
- Market Cap
- BBNX 841.5M
- SABR 981.2M
- IPO Year
- BBNX 2025
- SABR 2014
- Fundamental
- Price
- BBNX $17.89
- SABR $2.63
- Analyst Decision
- BBNX Strong Buy
- SABR Hold
- Analyst Count
- BBNX 10
- SABR 5
- Target Price
- BBNX $25.20
- SABR $4.12
- AVG Volume (30 Days)
- BBNX 504.1K
- SABR 5.4M
- Earning Date
- BBNX 08-06-2025
- SABR 07-31-2025
- Dividend Yield
- BBNX N/A
- SABR N/A
- EPS Growth
- BBNX N/A
- SABR N/A
- EPS
- BBNX N/A
- SABR N/A
- Revenue
- BBNX $69,830,000.00
- SABR $3,023,296,000.00
- Revenue This Year
- BBNX $32.79
- SABR $2.85
- Revenue Next Year
- BBNX $36.59
- SABR $3.47
- P/E Ratio
- BBNX N/A
- SABR N/A
- Revenue Growth
- BBNX 38911.17
- SABR 2.56
- 52 Week Low
- BBNX $8.89
- SABR $1.93
- 52 Week High
- BBNX $24.50
- SABR $4.63
- Technical
- Relative Strength Index (RSI)
- BBNX N/A
- SABR 46.92
- Support Level
- BBNX N/A
- SABR $2.57
- Resistance Level
- BBNX N/A
- SABR $3.03
- Average True Range (ATR)
- BBNX 0.00
- SABR 0.14
- MACD
- BBNX 0.00
- SABR -0.02
- Stochastic Oscillator
- BBNX 0.00
- SABR 29.20
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
About SABR Sabre Corporation
Sabre holds the number-two air booking volume share in the global distribution system industry. The travel solutions segment represented 91% of total 2024 revenue, split between distribution (79% of segment sales) and airline IT solutions (21%) revenue. The company also has a growing hotel IT solutions division (9% of revenue). Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.